IRD
Opus Genetics, Inc.$3.50-0.07 (-1.83%)Prev Close$3.56·MCap$331.9M·P/E—·Vol553.8K·Yield—
▲
Buys (12M)
1
$323.7K
▼
Sells (12M)
13
$16.40M
◆
Net Activity
Net Seller
$16.07M
●
Active Insiders
8
last 12 mo
Over the past 12 months, insider activity at Opus Genetics, Inc. (IRD) has been dominated by selling, with 1 insider purchase totaling $323.7K and 13 insider sales totaling $16.40M. The most recent insider transaction was by Foundation Fighting Blindness Retinal Degeneration Fund (director, other: See Remarks), who sold $7.39M worth of shares on May 20, 2026. Opus Genetics, Inc. operates in the Healthcare sector, within the Biotechnology industry, with a market cap of $331.9M.
IRD Insider Trading Activity
| Date | Insider | Role | Type | Shares | Avg Price | Value | Shares After |
|---|---|---|---|---|---|---|---|
| May 20, 2026 | Foundation Fighting Blindness Retinal Degeneration Fund | director, other: See Remarks | Sell | 1,700,000 | $4.35 | $7.39M2.1% OS | 3,792,171-31% |
| Apr 27, 2026 | YERXA BENJAMIN R | director, officer: President | Sell | 7,470 | $5.24 | $39.1K | 711,535 |
| Apr 27, 2026 | Gagnon Robert E. | officer: Chief Financial Officer | Sell | 7,842 | $5.18 | $40.7K | 592,158 |
| Apr 27, 2026 | Magrath George | director, officer: Chief Executive Officer | Sell | 9,511 | $5.22 | $49.6K | 1,741,344 |
| Apr 27, 2026 | SCHACHLE JOSEPH K | officer: Chief Operating Officer | Sell | 4,697 | $5.22 | $24.5K | 296,084 |
| Apr 27, 2026 | Zaremba Rabourn Amy | officer: Head of Fin. Quality Assurance | Sell | 1,641 | $5.20 | $8.5K | 188,671 |
| Apr 27, 2026 | Jayagopal Ashwath | officer: Chief Scientific & Dev. Ofc. | Sell | 7,542 | $5.19 | $39.2K | 509,233 |
| Mar 18, 2026 | Jayagopal Ashwath | officer: Chief Scientific & Dev. Ofc. | Sell | 3,719 | $5.12 | $19.0K | 516,775 |
| Mar 18, 2026 | Magrath George | director, officer: Chief Executive Officer | Sell | 24,438 | $5.21 | $127.3K | 1,750,855 |
| Mar 18, 2026 | SCHACHLE JOSEPH K | officer: Chief Operating Officer | Sell | 3,719 | $5.25 | $19.5K | 300,781 |
| Mar 18, 2026 | Zaremba Rabourn Amy | officer: Head of Fin. Quality Assurance | Sell | 2,816 | $5.24 | $14.8K | 190,312 |
| Feb 12, 2026 | Jayagopal Ashwath | Chief Scientific & Dev. Ofc. | Sell | 5,313 | $3.39 | $18.0K | 0 |
| Dec 31, 2025 | Gallagher Cam | Buy | 164,000 | $1.97 | $323.7K | 1,891,430 | |
| Dec 11, 2025 | Foundation Fighting Blindness Retinal Degeneration Fund | Director | Sell | 4,000,000 | $2.15 | $8.60M5.6% OS | 5,492,171-42% |
| Dec 30, 2024 | Magrath George | Chief Executive Officer | Buy | 100,000 | $0.98 | $97.6K | 599,150 |
| Nov 25, 2024 | YERXA BENJAMIN R | President | Buy | 10,000 | $0.98 | $9.8K | 342,800 |
| Nov 19, 2024 | Magrath George | Chief Executive Officer | Buy | 100,000 | $1.01 | $101.2K | 492,950+25% |
| May 24, 2024 | Jayagopal Ashwath | Chief Scientific & Dev. Ofc. | Buy | 3,500 | $1.77 | $6.2K | 78,500 |
| May 21, 2024 | Magrath George | Chief Executive Officer | Buy | 5,000 | $1.75 | $8.8K | 430,000 |
| Mar 25, 2024 | Jhaveri Nirav S. | Chief Financial Officer | Buy | 10,000 | $2.10 | $21.0K | 150,000 |
| Mar 25, 2024 | SCHACHLE JOSEPH K | Chief Operating Officer | Buy | 2,000 | $2.05 | $4.1K | 2,000 |
| Mar 20, 2024 | Magrath George | Chief Executive Officer | Buy | 25,000 | $1.96 | $49.0K | 425,000 |
| May 24, 2022 | MANUSO JAMES S J | Buy | 5,000 | $1.99 | $9.9K | 21,570+30% | |
| May 23, 2022 | Sooch Mina | President and CEO | Buy | 25,000 | $2.05 | $51.2K | 425,022 |
| Dec 14, 2021 | Pepose Jay | Buy | 8,250 | $3.65 | $30.1K | 22,994+56% | |
| Nov 22, 2021 | MANUSO JAMES S J | Buy | 2,000 | $3.50 | $7.0K | 16,570 | |
| Sep 15, 2021 | Pepose Jay | Buy | 12,631 | $4.75 | $60.0K | 14,744+598% | |
| Sep 3, 2021 | Benton Susan | Buy | 20,000 | $4.57 | $91.4K | 23,976+503% |
IRD Insider Buying Activity
The following table shows recent insider purchases of Opus Genetics, Inc. (IRD) stock reported via SEC Form 4 filings.
| Date | Insider | Role | Type | Shares | Avg Price | Value | Shares After |
|---|---|---|---|---|---|---|---|
| Dec 31, 2025 | Gallagher Cam | Buy | 164,000 | $1.97 | $323.7K | 1,891,430 | |
| Dec 30, 2024 | Magrath George | Chief Executive Officer | Buy | 100,000 | $0.98 | $97.6K | 599,150 |
| Nov 25, 2024 | YERXA BENJAMIN R | President | Buy | 10,000 | $0.98 | $9.8K | 342,800 |
| Nov 19, 2024 | Magrath George | Chief Executive Officer | Buy | 100,000 | $1.01 | $101.2K | 492,950+25% |
| May 24, 2024 | Jayagopal Ashwath | Chief Scientific & Dev. Ofc. | Buy | 3,500 | $1.77 | $6.2K | 78,500 |
| May 21, 2024 | Magrath George | Chief Executive Officer | Buy | 5,000 | $1.75 | $8.8K | 430,000 |
| Mar 25, 2024 | Jhaveri Nirav S. | Chief Financial Officer | Buy | 10,000 | $2.10 | $21.0K | 150,000 |
| Mar 25, 2024 | SCHACHLE JOSEPH K | Chief Operating Officer | Buy | 2,000 | $2.05 | $4.1K | 2,000 |
| Mar 20, 2024 | Magrath George | Chief Executive Officer | Buy | 25,000 | $1.96 | $49.0K | 425,000 |
| May 24, 2022 | MANUSO JAMES S J | Buy | 5,000 | $1.99 | $9.9K | 21,570+30% | |
| May 23, 2022 | Sooch Mina | President and CEO | Buy | 25,000 | $2.05 | $51.2K | 425,022 |
| Dec 14, 2021 | Pepose Jay | Buy | 8,250 | $3.65 | $30.1K | 22,994+56% | |
| Nov 22, 2021 | MANUSO JAMES S J | Buy | 2,000 | $3.50 | $7.0K | 16,570 | |
| Sep 15, 2021 | Pepose Jay | Buy | 12,631 | $4.75 | $60.0K | 14,744+598% | |
| Sep 3, 2021 | Benton Susan | Buy | 20,000 | $4.57 | $91.4K | 23,976+503% |
IRD Insider Selling Activity
The following table shows recent insider sales of Opus Genetics, Inc. (IRD) stock reported via SEC Form 4 filings.
| Date | Insider | Role | Type | Shares | Avg Price | Value | Shares After |
|---|---|---|---|---|---|---|---|
| May 20, 2026 | Foundation Fighting Blindness Retinal Degeneration Fund | director, other: See Remarks | Sell | 1,700,000 | $4.35 | $7.39M2.1% OS | 3,792,171-31% |
| Apr 27, 2026 | YERXA BENJAMIN R | director, officer: President | Sell | 7,470 | $5.24 | $39.1K | 711,535 |
| Apr 27, 2026 | Gagnon Robert E. | officer: Chief Financial Officer | Sell | 7,842 | $5.18 | $40.7K | 592,158 |
| Apr 27, 2026 | Magrath George | director, officer: Chief Executive Officer | Sell | 9,511 | $5.22 | $49.6K | 1,741,344 |
| Apr 27, 2026 | SCHACHLE JOSEPH K | officer: Chief Operating Officer | Sell | 4,697 | $5.22 | $24.5K | 296,084 |
| Apr 27, 2026 | Zaremba Rabourn Amy | officer: Head of Fin. Quality Assurance | Sell | 1,641 | $5.20 | $8.5K | 188,671 |
| Apr 27, 2026 | Jayagopal Ashwath | officer: Chief Scientific & Dev. Ofc. | Sell | 7,542 | $5.19 | $39.2K | 509,233 |
| Mar 18, 2026 | Jayagopal Ashwath | officer: Chief Scientific & Dev. Ofc. | Sell | 3,719 | $5.12 | $19.0K | 516,775 |
| Mar 18, 2026 | Magrath George | director, officer: Chief Executive Officer | Sell | 24,438 | $5.21 | $127.3K | 1,750,855 |
| Mar 18, 2026 | SCHACHLE JOSEPH K | officer: Chief Operating Officer | Sell | 3,719 | $5.25 | $19.5K | 300,781 |
| Mar 18, 2026 | Zaremba Rabourn Amy | officer: Head of Fin. Quality Assurance | Sell | 2,816 | $5.24 | $14.8K | 190,312 |
| Feb 12, 2026 | Jayagopal Ashwath | Chief Scientific & Dev. Ofc. | Sell | 5,313 | $3.39 | $18.0K | 0 |
| Dec 11, 2025 | Foundation Fighting Blindness Retinal Degeneration Fund | Director | Sell | 4,000,000 | $2.15 | $8.60M5.6% OS | 5,492,171-42% |
IRD Insiders
Foundation Fighting Blindness Retinal Degeneration Fund
director, other: See Remarks
Sold $15.99M
2 tradesLast: May 20, 2026
Magrath George
director, officer: Chief Executive Officer
Bought $256.6KSold $177.0K
6 tradesLast: Apr 27, 2026
Jayagopal Ashwath
officer: Chief Scientific & Dev. Ofc.
Bought $6.2KSold $76.2K
4 tradesLast: Apr 27, 2026
Similar Stocks to IRD
VRTX
Vertex Pharmaceuticals Incorporated
$476.29+0.08%
$126.50B
REGN
Regeneron Pharmaceuticals, Inc.
$662.73+1.01%
$68.29B
ALNY
Alnylam Pharmaceuticals, Inc.
$275.93-1.72%
$43.19B
RVMD
Revolution Medicines, Inc.
$185.71+0.42%
$40.34B
MRNA
Moderna, Inc.
$68.11+1.00%
$27.09B
INSM
Insmed Incorporated
$109.25-0.67%
$25.06B
INCY
Incyte Corporation
$114.43-0.30%
$23.32B
UTHR
United Therapeutics Corporation
$530.63+0.75%
$23.22B